Personalized Cancer Treatment for Ovarian Cancer

被引：7

作者：

Chumworathayi, Bandit ^{[1
]}

机构：

[1] Khon Kaen Univ, Fac Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Khon Kaen, Thailand

来源：

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION | 2013年 / 14卷 / 03期

关键词：

Ovarian cancers; Burzynski approach; personalized treatment; BREAST-CANCER; PROGNOSTIC VALUE; NODAL RATIOS; METASTASIS; SURVIVAL; ESTROGEN;

D O I：

10.7314/APJCP.2013.14.3.1661

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Recently there have been numerous advances in understanding the genetic basis of cancer which have resulted in more appropriate treatments. In this paper we describe the experience of the Burzynski Clinic, involved in treatment of numerous patients based on personalized approach using novel combinations for difficult-to-treat malignancies, with gynecological cancers. This retrospective study was conducted by extracting data from Burzynski Clinic's medical records and comprehensive review. Among the advanced refractory ovarian cancers cases (N=33), an objective response (OR) was found in 42.4%. We anticipate that with improved technology and novel therapeutics this rate will increase and adverse events will be reduced.

引用

页码：1661 / 1667

页数：7

共 19 条

[1]

ALANKO A, 1985, CANCER-AM CANCER SOC, V56, P1696, DOI 10.1002/1097-0142(19851001)56:7<1696::AID-CNCR2820560738>3.0.CO

[2]

2-N

[3] Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system [J].

Barnholtz-Sloan, JS ;

Sloan, AE ;

Davis, FG ;

Vigneau, FD ;

Lai, P ;

Sawaya, RE .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :2865-2872

[4] Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers [J].

Chia, Stephen ;

Norris, Brian ;

Speers, Caroline ;

Cheang, Maggie ;

Gilks, Blake ;

Gown, Allen M. ;

Huntsman, David ;

Olivotto, Ivo A. ;

Nielsen, Torsten O. ;

Gelmon, Karen .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (35) :5697-5704

[5] The factors that have an impact on the development of brain metastasis in the patients with breast cancer [J].

Dayan, Adem ;

Koca, Dogan ;

Akman, Tulay ;

Oztop, Ilhan ;

Ellidokuz, Hulya ;

Yilmaz, Ugur .

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2012, 8 (04) :542-548

[6] Determinants and prognoses of locoregional and distant progression in breast cancer [J].

Engel, J ;

Eckel, R ;

Aydemir, Ü ;

Aydemir, S ;

Kerr, J ;

Schlesinger-Raab, A ;

Dirschedl, P ;

Hölzel, D .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (05) :1186-1195

[7] Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 [J].

Goldhirsch, A. ;

Wood, W. C. ;

Coates, A. S. ;

Gelber, R. D. ;

Thuerlimann, B. ;

Senn, H. -J. .

ANNALS OF ONCOLOGY, 2011, 22 (08) :1736-1747

[8] Stability of Estrogen Receptor Status in Breast Carcinoma A Comparison Between Primary and Metastatic Tumors With Regard to Disease Course and Intervening Systemic Therapy [J].

Gong, Yun ;

Han, Eric Yulong ;

Guo, Ming ;

Pusztai, Lajos ;

Sneige, Nour .

CANCER, 2011, 117 (04) :705-713

[9]

Greene F., 2002, AJCC cancer staging handbook: From the AJCC cancer staging manual, V6th

[10] Ratio Between Positive Lymph Nodes and Total Excised Axillary Lymph Nodes as an Independent Prognostic Factor for Overall Survival in Patients with Nonmetastatic Lymph Node-Positive Breast Cancer [J].

Hatoum, Hassan A. ;

Jamali, Faek R. ;

El-Saghir, Nagi S. ;

Musallam, Khaled M. ;

Seoud, Muhieddine ;

Dimassi, Hani ;

Abbas, Jaber ;

Khalife, Mohamad ;

Boulos, Fouad I. ;

Tawil, Ayman N. ;

Geara, Fadi B. ;

Salem, Ziad ;

Shamseddine, Achraf A. ;

Al-Feghali, Karine ;

Shamseddine, Ali I. .

ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (12) :3388-3395

← 1 2 →